// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Before COVID-19, most people might vaguely remember messenger RNA (mRNA) from a high school biolo
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and
For people living in rural areas of the U.S., access to healthcare providers can be a serious cha